NO159850C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.Info
- Publication number
- NO159850C NO159850C NO820979A NO820979A NO159850C NO 159850 C NO159850 C NO 159850C NO 820979 A NO820979 A NO 820979A NO 820979 A NO820979 A NO 820979A NO 159850 C NO159850 C NO 159850C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pyridine derivatives
- therapeutic active
- analogy procedure
- active pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8106005A FR2502618A1 (fr) | 1981-03-25 | 1981-03-25 | Derives de pyridine, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO820979L NO820979L (no) | 1982-09-27 |
| NO159850B NO159850B (no) | 1988-11-07 |
| NO159850C true NO159850C (no) | 1989-02-15 |
Family
ID=9256643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO820979A NO159850C (no) | 1981-03-25 | 1982-03-24 | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4406907A (fi) |
| EP (1) | EP0061379B1 (fi) |
| JP (1) | JPS57169462A (fi) |
| AR (1) | AR231281A1 (fi) |
| AT (1) | ATE15895T1 (fi) |
| AU (1) | AU545747B2 (fi) |
| CA (1) | CA1185978A (fi) |
| DE (1) | DE3266607D1 (fi) |
| DK (1) | DK156652C (fi) |
| ES (1) | ES510724A0 (fi) |
| FI (1) | FI75808C (fi) |
| FR (1) | FR2502618A1 (fi) |
| GR (1) | GR75930B (fi) |
| HU (1) | HU186488B (fi) |
| IE (1) | IE52654B1 (fi) |
| IL (1) | IL65336A (fi) |
| MX (1) | MX156114A (fi) |
| NO (1) | NO159850C (fi) |
| NZ (1) | NZ200118A (fi) |
| ZA (1) | ZA822008B (fi) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6218598A (en) * | 1997-01-30 | 1998-08-25 | Synthelabo | Alpha-azacyclomethyl benzothiophene and alpha-azacyclomethyl benzofurane derivatives, preparation and therapeutic application |
| FR2758820B1 (fr) * | 1997-01-30 | 1999-02-26 | Synthelabo | Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique |
| WO2021023209A1 (zh) | 2019-08-05 | 2021-02-11 | 北京志健金瑞生物医药科技有限公司 | 含氮多环稠环类化合物，其药物组合物、制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4195090A (en) * | 1973-02-20 | 1980-03-25 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith |
| US4115575A (en) * | 1973-02-20 | 1978-09-19 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)-pyrazines |
| AR208397A1 (es) * | 1973-02-20 | 1976-12-27 | Ciba Geigy Ag | Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan |
-
1981
- 1981-03-25 FR FR8106005A patent/FR2502618A1/fr active Granted
-
1982
- 1982-03-08 DE DE8282400397T patent/DE3266607D1/de not_active Expired
- 1982-03-08 EP EP82400397A patent/EP0061379B1/fr not_active Expired
- 1982-03-08 AT AT82400397T patent/ATE15895T1/de not_active IP Right Cessation
- 1982-03-23 GR GR67694A patent/GR75930B/el unknown
- 1982-03-23 MX MX191934A patent/MX156114A/es unknown
- 1982-03-24 IL IL65336A patent/IL65336A/xx unknown
- 1982-03-24 NO NO820979A patent/NO159850C/no unknown
- 1982-03-24 FI FI821034A patent/FI75808C/fi not_active IP Right Cessation
- 1982-03-24 ZA ZA822008A patent/ZA822008B/xx unknown
- 1982-03-24 ES ES510724A patent/ES510724A0/es active Granted
- 1982-03-24 DK DK133282A patent/DK156652C/da not_active IP Right Cessation
- 1982-03-24 CA CA000399301A patent/CA1185978A/en not_active Expired
- 1982-03-24 AR AR288854A patent/AR231281A1/es active
- 1982-03-24 IE IE682/82A patent/IE52654B1/en unknown
- 1982-03-24 NZ NZ200118A patent/NZ200118A/en unknown
- 1982-03-24 US US06/361,200 patent/US4406907A/en not_active Expired - Fee Related
- 1982-03-24 AU AU81873/82A patent/AU545747B2/en not_active Ceased
- 1982-03-24 HU HU82893A patent/HU186488B/hu not_active IP Right Cessation
- 1982-03-24 JP JP57047061A patent/JPS57169462A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE3266607D1 (en) | 1985-11-07 |
| FI821034L (fi) | 1982-09-26 |
| US4406907A (en) | 1983-09-27 |
| NZ200118A (en) | 1984-09-28 |
| GR75930B (fi) | 1984-08-02 |
| DK133282A (da) | 1982-09-26 |
| ES8303346A1 (es) | 1983-02-01 |
| IE52654B1 (en) | 1988-01-06 |
| FR2502618B1 (fi) | 1983-12-23 |
| NO820979L (no) | 1982-09-27 |
| ATE15895T1 (de) | 1985-10-15 |
| IL65336A (en) | 1985-08-30 |
| EP0061379B1 (fr) | 1985-10-02 |
| EP0061379A1 (fr) | 1982-09-29 |
| HU186488B (en) | 1985-08-28 |
| AU545747B2 (en) | 1985-08-01 |
| IL65336A0 (en) | 1982-05-31 |
| DK156652B (da) | 1989-09-18 |
| MX156114A (es) | 1988-07-12 |
| CA1185978A (en) | 1985-04-23 |
| FI75808B (fi) | 1988-04-29 |
| FR2502618A1 (fr) | 1982-10-01 |
| DK156652C (da) | 1990-02-05 |
| AR231281A1 (es) | 1984-10-31 |
| FI821034A0 (fi) | 1982-03-24 |
| NO159850B (no) | 1988-11-07 |
| ZA822008B (en) | 1983-02-23 |
| IE820682L (en) | 1982-09-25 |
| FI75808C (fi) | 1988-08-08 |
| AU8187382A (en) | 1982-09-30 |
| JPS6135185B2 (fi) | 1986-08-12 |
| ES510724A0 (es) | 1983-02-01 |
| JPS57169462A (en) | 1982-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO162022C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater. | |
| NO158099C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO156864B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater. | |
| NO159531C (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater. | |
| NO159446C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater. | |
| NO167142C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO161117C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater. | |
| NO162514C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater. | |
| NO165239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater. | |
| NO165192C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater. | |
| NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
| NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO159654C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater. | |
| NO161562C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater. | |
| NO159930C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater. | |
| NO161676C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater. | |
| NO161559C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO160079C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater. | |
| NO158941C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater. | |
| NO158739C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
| NO160511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater. | |
| NO160512C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO168478C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater. | |
| NO154052C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater. |